SGLT2 inhibitors, GLP-1 RAs, and DPP4 inhibitors and the risk of hypomagnesemia in type 2 diabetes: A target trial emulation

Journal:
PLOS Medicine
Published:
DOI:
10.1371/journal.pmed.1004968
Affiliations:
5
Authors:
5
Go to article
Institutions Authors Share
National Cheng Kung University (NCKU), Taiwan
4.166667
 0.83
National Cheng Kung University Hospital, Taiwan
0.500000
 0.10
Keelung Chang Gung Memorial Hospital, Chang Gung Medical Foundation, Taiwan
0.333333
 0.07
Interested in Pharmacology and Pharmaceutical Sciences?